Tower Research Capital LLC (Trc) Kiromic Biopharma, Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.16 - $11.77 $31 - $2,342	-199 Reduced 4.08%	4,675 $1,000
Q3 2022 Nov 10, 2022	SELL	$0.26 - $10.2 $11 - $469	-46 Reduced 0.93%	4,874 $1,000
Q2 2022 Aug 15, 2022	BUY	$0.26 - $0.87 $1,279 - $4,280	4,920 New	4,920 $2,000
Q4 2021 Feb 14, 2022	SELL	$1.53 - $3.12 $1,239 - $2,527	-810 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.69 - $4.94 $2,178 - $4,001	810 New	810 $2,000
Q2 2021 Aug 16, 2021	SELL	$4.81 - $10.34 $240 - $517	-50 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.2 - $11.81 $49,060 - $70,659	-5,983 Reduced 99.17%	50 $0
Q4 2020 Feb 16, 2021	BUY	$8.11 - $11.5 $48,927 - $69,379	6,033 New	6,033 $51,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $22.2M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.